Shacklett Barbara L, Derdeyn Cynthia A, Folayan Morenike Oluwatoyin, Landovitz Raphael J, Anthony Colin, Behrens Anna-Janina, Hope Thomas J, Landais Elise, Leal Lorna, Marrazzo Jeanne M, Morris Lynn, Mugo Nelly, Ngure Kenneth, Noseda Veronica, Ranasinghe Srinika, Tully Damien C, Voronin Yegor, Warren Mitchell, Wibmer Constantinos Kurt, Xie Irene Y, Scarlatti Gabriella, Thyagarajan Bargavi
1 Department of Medical Microbiology and Immunology and Division of Infectious Diseases, Department of Medicine, School of Medicine, University of California at Davis , Davis, California.
2 Department of Pathology and Laboratory Medicine, Emory University , Atlanta, Georgia .
AIDS Res Hum Retroviruses. 2017 Aug;33(8):749-759. doi: 10.1089/AID.2017.0125. Epub 2017 Jul 26.
HIV Research for Prevention: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P) was built on a growing consensus that effective HIV prevention requires a combination of approaches and that understanding, analyzing, and debating the cross-cutting issues that impact prevention research are all essential to combat the global HIV/AIDS epidemic. To that end, the biennial HIVR4P conference is dedicated to all biomedical HIV prevention research approaches, including HIV vaccines, microbicides, pre-exposure prophylaxis, and treatment as prevention. The HIVR4P 2016 conference was held in Chicago, Illinois (USA), on October 17-21, and included more than 700 scientific presentations and 21 satellite sessions covering the latest and most promising advances across the HIV prevention research field. The theme "Partnering for Prevention" represented the conference's commitment to breaking down silos between research disciplines as well as between researchers, program developers, care providers, advocates, communities, and funders. Delegates spanning 42 countries attended the conference. One-third of those in attendance were early career investigators, which reflects a firm commitment to emerging researchers and ultimately to the goal of developing a sustainable scientific enterprise well into the future. This article presents a concise summary of highlights from the conference. For a more detailed account, one may find full abstracts, daily summaries, and webcasts on the conference website at hivr4p.org.
艾滋病疫苗、杀微生物剂及基于抗逆转录病毒药物的预防科学（HIVR4P）建立在这样一种日益形成的共识之上，即有效的艾滋病病毒预防需要多种方法相结合，并且理解、分析和辩论影响预防研究的交叉问题对于抗击全球艾滋病疫情至关重要。为此，两年一度的HIVR4P会议致力于所有生物医学艾滋病病毒预防研究方法，包括艾滋病疫苗、杀微生物剂、暴露前预防以及治疗即预防。2016年HIVR4P会议于10月17日至21日在美国伊利诺伊州芝加哥举行，包括700多场科学报告和21场卫星会议，涵盖了艾滋病病毒预防研究领域的最新和最有前景的进展。“携手预防”这一主题体现了会议致力于打破研究学科之间以及研究人员、项目开发者、护理提供者、倡导者、社区和资助者之间的壁垒。来自42个国家的代表出席了会议。与会人员中有三分之一是早期职业研究人员，这反映了对新兴研究人员的坚定承诺，最终也是对发展可持续科学事业直至未来的目标的承诺。本文简要总结了会议亮点。如需更详细的内容，可在会议网站hivr4p.org上查找完整摘要、每日总结和网络直播。
